Ozempic Insights
Ozempic, priced at around $907 for a 30-day supply, is positioned as a valuable investment for those looking to reduce their BMI significantly. The drug's origins trace back to research funded by the Department of Veteran Affairs, highlighting a fascinating link to a hormone found in Gila monster venom. As sales soar, the pharmaceutical company behind Ozempic has seen its stock rise by 40%, contrasting sharply with the S&P’s decline. The discussion also touches on the politicization of obesity and the need for a candid dialogue about health comorbidities, especially in the context of the pandemic.In this clip
From this podcast
Prof G Markets
Prof G Markets: Scott’s NJOY Stake, the JetBlue/Spirit Merger, and WeightWatchers Buys Ozempic Maker
Related Questions